Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: a randomized controlled trial

References

• Almeda , J. , Casabona , J. , Simon , B. , Gerard , M. , Rey , D. , Puro , V. , & Thomas , T. on behalf of the Euro-NONOPEP Project Group . 2004 . Proposed recommendations for the management of HIV post-exposure prophylaxis after sexual, injecting drug or other exposures in Europe . Euro Surveillance , 9 , 35 40 .
   PubMedGoogle Scholar
• Cardo , D.M. , Culver , D.H. , Ciesielski , C.A. , Srivastava , P.U. , Marcus , R. , Abiteboul , D. , Bell , D.M. 1997 . A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group . New England Journal of Medicine , 337 , 1542 1543 .
   PubMed Web of Science ®Google Scholar
• Carrieri , P. , & the APROCO cohort 2001 . The dynamic of adherence to highly active antiretroviral therapy: Results from the French National APROCO cohort . Journal of Acquired Immune Deficiency Syndrome , 28 , 232 239 .
   PubMed Web of Science ®Google Scholar
• Center for Disease Control [CDC] . 2005 . Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States. Recommendations from the U.S. Department of Health and Human Services . MMWR. Recommendations and Reports , 54(RR-2), 1–20. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5402a1.htm
   Google Scholar
• Center for Disease Control [CDC] . 2006 . Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings . MMWR Recommendations and Reports , 55(RR14), 1–17. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm
   Google Scholar
• Center for Disease Control [CDC] . 2008 . Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection . MMWR Recommendations and Reports , 57(RR-9) , 1 83 ; quiz CE1-4. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5709a1.htm
   Google Scholar
• Chesney , M.A. 2000 . Factors affecting adherence to antiretroviral therapy . Clinical Infectious Diseases , 30 ( Suppl. 2 ) : S171 – S176 .
   PubMed Web of Science ®Google Scholar
• Day , S. , Mears , A. , Bond , K. and Kulasegaram , R. 2006 . Post-exposure HIV prophylaxis following sexual exposure: A retrospective audit against recent draft BASHH guidance . Sexually Transmitted Infections , 82 : 236 – 237 .
   PubMed Web of Science ®Google Scholar
• Deschamps , A.E. , De Geest , S. , Vandamme , A.M. , Bobbaers , H. , Peetermans , W.E. and Van Wijngaerden , E. 2008 . Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards . AIDS Patient Care and STDS , 22 : 735 – 743 .
   PubMed Web of Science ®Google Scholar
• Duran , S. , & the APROCO Cohort Study Group 2001 . Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART . HIV Clinical Trials , 2 , 38 45 .
   PubMedGoogle Scholar
• Fisher , J. D. , Cornman , D. H. , Norton , W. E. and Fisher , W. A. 2006 . UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure . International Journal of STD & AIDS , 17 : 81 – 92 .
   PubMed Web of Science ®Google Scholar
• Golub , S.A. , Rosenthal , L. , Cohen , D.E. and Mayer , K.H. 2008 . Determinants of high-risk sexual behavior during post-exposure prophylaxis to prevent HIV infection . AIDS and Behavior , 12 : 852 – 859 .
   PubMed Web of Science ®Google Scholar
• Goujard , C. , Bernard , N. , Sohier , N. , Peyramond , D. , Lancon , F. , Chwalow , J. and Delfraissy , J.F. 2003 . Impact of a patient education program on adherence to HIV medication: A randomized clinical trial . Journal of Acquired Immune Deficiency Syndrome , 34 : 191 – 194 .
   PubMed Web of Science ®Google Scholar
• Kahn , J.O. , Martin , J.N. , Roland , M.E. , Bamberger , J.D. , Chesney , M. , Chambers , D. and Katz , M.H. 2001 . Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: The San Francisco PEP study . Journal of Infectious Diseases , 183 : 707 – 714 .
   PubMed Web of Science ®Google Scholar
• Knobel , H. , Carmona , A. , Lopez , J.L. , Gimeno , J.L. , Saballs , P. , González , A. and Díez , A. 1999 . Adherence to very active antiretroviral treatment: Impact of individualized assessment . Enfermedades Infecciosas y Microbiología Clínica , 17 : 78 – 81 .
   PubMedGoogle Scholar
• Lacombe , K. , Daguenel-Nguyen , A. , Lebeau , V. , Fonquernie , L. , Girard , P.M. and Meyohas , M.C. 2006 . Determinants of adherence to non-occupational post HIV exposure prophylaxis . AIDS , 20 : 291 – 294 .
   PubMed Web of Science ®Google Scholar
• Laporte , A. , Jourdan , N. , Bouvet , E. , Lamontagne , F. , Pillonel , J. and Desenclos , J.C. 2002 . Post-exposure prophylaxis after non-occupational HIV exposure: Impact of recommendations on physicians’ experiences and attitudes . AIDS , 16 : 397 – 405 .
   PubMed Web of Science ®Google Scholar
• Lot , F. , Larsen , C. , & Herida , M. 2007 . Prophylaxie post-exposition au VIH: Evaluation nationale et étude coût efficacité [HIV post-exposure prophylaxis: National evaluation and cost-effectiveness] . Saint Maurice: Institut National de Veille Sanitaire , Lutte contre le VIH/Sida et les infections sexuellement transmissibles en France-10 ans de surveillance, 1996–2005 [Ten years' surveillance of HIV/AIDS and STI control in France, 1996–2005] (pp. 114 121 . Saint Maurice: Institut de Veille Sanitaire. Retrieved from http://www.invs.sante.fr/publications/2007/10ans_vih
   Google Scholar
• Luque , A. , Hulse , S. , Wang , D. , Shahzad , U. , Tanzman , E. , Antenozzi , S. and Smith , B. 2007 . Assessment of adverse events associated with antiretroviral regimens for postexposure prophylaxis for occupational and non occupational exposures to prevent transmission of human immunodeficiency virus . Infection Control and Hospital Epidemiology , 28 : 695 – 701 .
   PubMed Web of Science ®Google Scholar
• Mayer , K.H. , Mimiaga , M.J. , Cohen , D. , Grasso , C. , Bill , R. , Van Derwarker , R. and Fisher , A. 2008 . Tenofovir DF plus lamivudine or emtricitabine for nonoccupational postexposure prophylaxis (NPEP) in a Boston Community Health Center . Journal of Acquired Immune Deficiency Syndrome , 47 : 494 – 499 .
   PubMed Web of Science ®Google Scholar
• Miller , L.G. and Hays , R.D. 2000 . Adherence to combination antiretroviral therapy: Synthesis of the literature and clinical implications . AIDS Reader , 10 : 177 – 185 .
   PubMedGoogle Scholar
• Miller , W.R. , Zweben , A. , DiClemente , C.C. , & Rychtarik , R. 1992 . Motivational enhancement therapy manual: A clinical research guide for therapists treating individuals with alcohol abuse and dependence 283 Rockville , MD : National Institute on Alcohol Abuse and Alcoholism .
   Google Scholar
• Moher , D. , Schulz , K.F. and Altman , D.G. 2001 . The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials . Lancet , 357 : 1191 – 1194 .
   PubMed Web of Science ®Google Scholar
• Moore , D.M. , Hogg , R.S. , Yip , B. , Wood , E. , Harris , M. and Montaner , J.S. 2006 . Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapy . HIV Medicine , 7 : 311 – 316 .
   PubMed Web of Science ®Google Scholar
• Pinkerton , S.D. , Martin , J.N. , Roland , M.E. , Katz , M.H. , Coates , T.J. and Kahn , J.O. 2004 . Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus . Archives of Internal Medicine , 164 : 46 – 54 .
   PubMed Web of Science ®Google Scholar
• Pradier , C. , Bentz , L. , Spire , B. , Tourette-Turgis , C. , Morin , M. , Souville , M. and Moatti , J.P. 2003 . Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study . HIV Clinical Trials , 4 : 121 – 131 .
   PubMed Web of Science ®Google Scholar
• Rey , D. , Bendiane , M.K. , Bouhnik , A.D. , Almeda , J. , Moatti , J.P. and Carrieri , M.P. 2008 . Physicians' and patients' adherence to antiretroviral prophylaxis after sexual exposure to HIV: Results from South-Eastern France . AIDS Care , 20 : 537 – 541 .
   PubMed Web of Science ®Google Scholar
• Roland , M.E. 2007 . Postexposure prophylaxis after sexual exposure to HIV . Current Opinion in Infectious Diseases , 20 : 39 – 46 .
   PubMed Web of Science ®Google Scholar
• Simoni , J.M. , Pearson , C.R. , Pantalone , D.W. , Marks , G. and Crepaz , N. 2006 . Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials . Journal of Acquired Immune Deficiency Syndrome , 43 ( Suppl. 1 ) : S23 – S35 .
   PubMed Web of Science ®Google Scholar
• Sonder , G.J. , van den Hoek , A. , Regez , R.M. , Brinkman , K. , Prins , J.M. , Mulder , J.W. and Coutinho , R.A. 2007 . Trends in HIV postexposure prophylaxis prescription and compliance after sexual exposure in Amsterdam, 2000–2004 . Sexually Transmitted Diseases , 34 : 288 – 293 .
   PubMed Web of Science ®Google Scholar
• Stephenson , J. and Imrie , J. 1998 . Why do we need randomised controlled trials to assess behavioural interventions? . BMJ , 316 : 611 – 613 .
   PubMed Web of Science ®Google Scholar
• Tuldra , A. , Fumaz , C.R. , Ferrer , M.J. , Bayes , R. , Arno , A. , Balague , M. and Clotet , B. 2000 . Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy . Journal of Acquired Immune Deficiency Syndrome , 25 : 221 – 228 .
   PubMed Web of Science ®Google Scholar
• Yeni , P. 2006 . Groupe d'experts, sous la direction de. Prise en charge des situations d'exposition au risque viral [Expert Group, under the supervision of. Management of viral risk exposure] . In Secrétariat d'Etat à la Santé , Prise en charge médicale des personnes infectées par le VIH. Recommandations du groupe d'experts [Medical management of HIV-infected persons. Expert recommendations] (pp. 302 317 . Paris : Médecine – Sciences Flammarion .
   Google Scholar